Stocks
Abbott LaboratoriesABT
NYSEHealthcareHealth Care Equipment & Supplies$108.03-0.11%
A diversified healthcare manufacturer with operations spanning medical devices, diagnostics, nutrition products, and branded generic pharmaceuticals, the company generates significant revenue from cardiovascular and diabetes care devices, including its FreeStyle Libre glucose monitoring system. Its diagnostics platforms are widely used in hospitals and laboratories, while its nutrition brands hold leading positions in pediatric and adult segments. Investors track the company for medical device growth, product pipeline developments, regulatory approvals, and exposure to global healthcare spending trends.
Market Cap: $187.7B52W Range: $105.27 – $139.06
Congressional Interest in Abbott Laboratories (ABT)
16 members of Congress have disclosed 50 trades in Abbott Laboratories (ABT), a Healthcare company. The buy/sell breakdown shows 29 purchases versus 21 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
16
Buys
29
Sells
21
Who in Congress Is Trading ABT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-06-16 | ROBERT J. WITTMAN | sell | $1K – $15K |
| 2022-06-01 | MICHAEL T. MCCAUL | sell | $1K – $15K |